Image

Global Iron Deficiency Injectable Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Iron Deficiency Injectable Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Iron Deficiency Injectable Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 11.12 USD Billion
Diagram Market Size (Forecast Year) USD 22.50 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Iron Deficiency Injectable Market, By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Others), Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Iron Deficiency Injectable Market

Iron Deficiency Injectable Market Analysis and Size

Iron deficiency injectables also aid in overcoming poor adherence, non-compliance, and adverse gastrointestinal effects of oral medicines. Increasing number of patients undergoing dialysis, growing incidence of elderly population globally, growing expenditure on medications, increasing incidences of iron deficiency anaemia are some of the major factors that are likely to boost the growth of the market.  Data Bridge Market Research analyses a growth rate in the iron deficiency injectable market in the forecast period 2023-2030. The expected CAGR of the iron deficiency injectable market tends to be around 9.20% in the mentioned forecast period. The market was valued at USD 11.12 billion in 2022 and would grow to USD 22.5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Iron Deficiency Injectable Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose, Others), Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

AbbVie Inc. (U.S.), Covis Pharma GmbH (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan), Fresenius Kabi AG (Germany), Vifor Pharma Management Ltd.(Switzerland), PHARMACOSMOS A/S (Denmark), Shield Therapeutics plc (U.K.), American Regent, Inc.(U.S.), Rockwell Medical, Inc. (U.S.), Apotex Inc (Canada), Bayer AG (Germany), Akebia Therapeutics, Inc.(U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Aetna Inc. (U.S.), Pfizer Inc (U.S.), Systacare Remedies (India), BSA Pharma Inc. (India)

Market Opportunities

  • Rising Incidences of Chrinic Diseases

Market Definition

Iron deficiency injectables are the drugs which are prescribed for treating iron deficiency and delivered by intravenous (IV) infusion in the body. These IV drugs offer numerous benefits over oral medications by guaranteeing faster absorption of the infused supplements. Iron-deficiency anaemia is a disorder in which the blood does not have enough healthy red blood cells due to the deficiency of iron. For treating these patiets, these injectables are used. It is used only for the treatment of patients who cannot be treated appropriately with oral iron supplements.

Iron Deficiency Injectable Market Dynamics

Drivers

  • Increase in Anemia Cases

Anemia is found to be one of the most common blood disorders in the recent times. As per the National Heart, Lung, and Blood Institute, an estimated 3 million individuals suffer from anemia in the U.S. growing incidence of target diseases, such as autoimmune diseases, cancer, rheumatoid arthritis, liver disorders, kidney conditions, thyroid diseases, and inflammatory bowel diseases, is a major factor which is facilitating the growth of the market.

  • Prevalence of PCOS

Polycystic ovary syndrome (PCOS) is the the major endocrinopathy among reproductive-aged women, which is not yet perceived as an important health problem in the world. It affects around 4%–20% of women of reproductive age globally. It has been reported that the incidence of PCOS is considered to be more in South Asians than in Caucasians who are residing in the U.K..

Opportunities

  • Rising Incidences of Chrinic Diseases

As per the National Kidney Foundation, Inc., the two major causes of chronic kidney disease are diabetes and hypertension. Several survey indicates an estimated 10% of the global population is affected by chronic kidney disease, with more than 2 million individuals receiving dialysis on a regular basis. It is projected that the occurrence of chronic kidney cases will increase across developing economies, such as India and China, that implies an increase in the elderly population in the coming years..

 Restraints/Challenges

  • Side Effects of Iron Drugs

Common adverse effects of iron drugs include digestive problems such as stomach aches, constipation, nausea, loss of appetite, and vomiting. The huge overdose of oral iron drugs may also include convulsions, shallow or rapid breathing, pale skin, tiredness or weakness, and bluish skin or fingernails.

This iron deficiency injectable market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the iron deficiency injectable market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Iron Deficiency Injectable Market Scope

The iron deficiency injectable market is segmented on the basis of product, application, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • Others

Application

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Iron Deficiency Injectable Market Regional Analysis/Insights

The iron deficiency injectable market is analysed and market size insights and trends are provided by product, application, distribution channel and end-user as referenced above.

The major countries covered in the iron deficiency injectable market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for the iron deficiency injectable market throughout the forecasted period due to the surging levels of investment the government for the growth of the biopharmaceutical and biotechnology industry along with development of novel drugs and innovative medical treatment in the region. 

North America dominates the market due to rising number of applications in cancer research along with adoption of low cost drugs in clinical diagnostics and development of research laboratories in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Iron Deficiency Injectable  Market Share Analysis

The iron deficiency injectable market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to iron deficiency injectable market.

Key players operating in the iron deficiency injectable market include:

  • AbbVie Inc. (U.S.)
  • Covis Pharma GmbH (U.S.)
  • DAIICHI SANKYO COMPANY, LIMITED (Japan)
  • Fresenius Kabi AG (Germany)
  • Vifor Pharma Management Ltd.(Switzerland)
  • PHARMACOSMOS A/S (Denmark)
  • Shield Therapeutics plc (U.K.)
  • American Regent, Inc. (U.S.)
  • Rockwell Medical, Inc. (U.S.)
  • Apotex Inc (Canada)
  • Bayer AG (Germany)
  • Akebia Therapeutics, Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Aetna Inc.(U.S.)
  • Pfizer Inc (U.S.)
  • Systacare Remedies (India)
  • BSA Pharma Inc. (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The iron deficiency injectable market was USD 11.12 billion in 2022.
The iron deficiency injectable market is projected to grow at a CAGR of 9.20% during the forecast period of 2023-2030.
The Iron Deficiency Injectable Market report is segmented by Product, Application, End-Users, and Distribution Channel.
North America dominates the market due to rising number of applications in cancer research along with adoption of low cost drugs in clinical diagnostics and development of research laboratories in the region.
The Asia-Pacific has been witnessing positive growth for the iron deficiency injectable market throughout the forecasted period 2022-2030.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials